| abstract |
The application area for the treatment of dendritic cells is being expanded, but since dendritic cell precursors are scarcely present in peripheral blood, it is in vitro to obtain an amount sufficient for treatment. It is still difficult to grow in Therefore, increasing the level of dendritic cell precursors in the peripheral blood of a patient is an important key in putting the treatment with dendritic cells into practical use. The present invention is an agent for increasing blood levels of dendritic cell precursors comprising an agonist for a receptor expressed in immature dendritic cells or a functional derivative thereof as an active ingredient. [Selection] Figure 2 |